# US 2012/0252013 A1 · Methods for identifying multiple dna alteration markers in a large background of wild-type dna

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252013 A1
- Document ID: US20120252013A1
- Status: Published application
- Kind: A1
- Application number: 13/324,425
- Filed: 2011-12-13
- Published: 2012-10-04
- Earliest claimed: 2005-10-14
- Assignees: Cleveland State University
- Inventors: Baochuan Guo
- Web page: https://patentgrep.com/patent/US20120252013A1

## CPC

- C12Q 1/6858: Allele-specific amplification
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/682: Signal amplification
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods for simultaneously surveying the status of a large number of DNA mutation markers are described. In addition, methods for simultaneously determining the methylation status at multiple sites of a collection of genes, in a single assay, are described.

## Claims

### Claim 1

A method for surveying the methylation status of a large number of CpG sites in a large background of unmethylated DNA, the method comprising:
providing a sample including methylated DNA and unmethylated DNA;
treating the sample to convert cytosine groups in the unmethylated DNA to uracil groups;
amplifying the treated sample by a first PCR with primers to thereby yield DNA fragments in which all uracil groups are converted to thymine groups;
enriching the methylated DNA by performing one or multiple cycles of methylation-specific enrichment cycles to thereby form an enriched system;
amplifying the enriched system by a second PCR to generate sufficient amounts of methylated DNA for detection; and
surveying the methylation status of the CpG sites.

### Claim 2 (depends on 1)

The method of claim 1 wherein the sample is obtained from clinical biospecimens collected from patients, the biospecimens selected from the group consisting of human tumor tissues, peripheral blood, stool, urine, bodily fluids, washing fluids associated with medical procedures, and combinations thereof.

### Claim 3 (depends on 1)

The method of claim 1 wherein the molar ratio of the unmethylated DNA to the methylated DNA is from about 2:1 to about 100,000:1 in the sample.

### Claim 4 (depends on 1)

The method of claim 1 wherein the CpG sites are in one or more genes.

### Claim 5 (depends on 1)

The method of claim 1 wherein the treating is performed by using a bisulfite reaction.

### Claim 6 (depends on 1)

The method of claim 1 wherein the first PCR is multiplexed PCR utilizing two or more pairs of PCR primers, wherein each pair of primers includes a forward primer and a reverse primer, wherein each pair of primers is adapted to amplify a sequence containing one or more of the CpG sites and wherein each primer further includes both a target-specific part and a universal tail part, wherein the target specific part flanks the sequence to allow for amplification of the sequence and the sequence of the universal tail part is the same for all forward and reverse primers, wherein the universal tail does not bind any DNA fragments produced by the treating operation.

### Claim 7 (depends on 1)

The method of claim 1 wherein the methylation-specific enrichment cycles are selected from the group consisting of (i) depleting unmethylated DNA, (ii) selectively capturing methylated DNA, and (iii) a combination of (i) and (ii).

### Claim 8 (depends on 1)

The method of claim 1 wherein enrichment of the methylated DNA fragments containing the methylated cytosine at CpG sites from the amplicons of the multiplexed PCR is performed by at least one of (i) methylation-specific hybridization and extraction and (ii) competing mutation-specific hybridization and extraction.

### Claim 9 (depends on 8)

The method of claim 8 wherein enriching is performed by methylation-specific hybridization and extraction, wherein a plurality of methylation-specific probes are contacted with the DNA fragments of the first PCR under hybridization conditions wherein each methylation-specific probe preferentially forms hybrids with a methylated sequence, wherein the methylation-specific probes are further attached to a first binding molecule that is capable of binding to a second binding molecule that is attached to a solid support, and wherein after hybridization, the hybrids are captured by the solid support containing the second binding molecule.

### Claim 10 (depends on 9)

The method of claim 9 wherein the number of methylation-specific hybridization and extraction cycles performed ranges from one cycle to five cycles.

### Claim 11 (depends on 10)

The method of claim 10 wherein the number of cycles is one.

### Claim 12 (depends on 10)

The method of claim 10 wherein the number of cycles is two or more.

### Claim 13 (depends on 12)

The method of claim 12 wherein the methylation-specific hybridization and extraction is repeated, wherein the DNA fragments captured by the solid support are released from the solid support and further subjected to additional cycles of the methylation-specific hybridization and extraction.

### Claim 14 (depends on 9)

The method of claim 9 wherein the methylation-specific probes are selected from the group consisting of oligonucleotides, peptide nucleic acids, locked nucleic acids, and combinations thereof.

### Claim 15 (depends on 9)

The method of claim 9 wherein the first binding molecule is selected from the group consisting of biotin, streptavidin, and combinations thereof and the second binding molecule is selected from the group consisting of streptavidin, biotin, and combinations thereof.

### Claim 16 (depends on 8)

The method of claim 8 wherein enriching of the methylated DNA fragments is performed by competing methylation-specific hybridization and extraction, wherein a plurality of methylation-specific probes and unmethylated competitor probes are contacted with the DNA fragments of the first PCR under hybridization conditions wherein the methylation-specific probes preferentially form hybrids with methylated DNA fragments, the corresponding unmethylated competitor probes preferentially form hybrids with the corresponding unmethylated DNA fragments, wherein the methylation-specific probes are further attached to a first binding molecule that is capable of binding to a second binding molecule that is attached to a solid support, and wherein after hybridization, the hybrids are captured by the solid support containing the second binding molecule.

### Claim 17 (depends on 16)

The method of claim 16 wherein the number of competing methylation-specific hybridization and extraction cycles performed ranges from one cycle to five cycles.

### Claim 18 (depends on 17)

The method of claim 17 wherein the number of cycles is one.

### Claim 19 (depends on 17)

The method of claim 17 wherein the number of cycles is two or more.

### Claim 20 (depends on 19)

The method of claim 19 wherein the competing methylation-specific hybridization and extraction is repeated, wherein the DNA fragments captured by the solid support are released from the solid support and further subjected to additional cycles of the competing methylation-specific hybridization and extraction.

### Claim 21 (depends on 16)

The method of claim 16 wherein the methylation-specific probes are selected from the group consisting of oligonucleotides, peptide nucleic acids, locked nucleic acids, and combinations thereof.

### Claim 22 (depends on 16)

The method of claim 16 wherein the first binding molecule is selected from the group consisting of biotin, streptavidin, and combinations thereof and the second binding molecule is selected from the group consisting of streptavidin, biotin, and combinations thereof.

### Claim 23 (depends on 16)

The method of claim 16 wherein the molar ratio of the methylation-specific hybridization probes to the corresponding unmethylated competitor probes is from about 0.02:1 to about 10:1.

### Claim 24 (depends on 1)

The method of claim 1 wherein the first PCR uses two or more pairs of primers, each pair of primers includes a forward primer and a reverse primer, each pair of primers including a universal tail, the second PCR is performed by contacting the enriched methylated DNA fragments with universal primers, wherein the universal primers hybridize to the universal tails of the forward and reverse primers to amplify all enriched DNA fragments.

### Claim 25 (depends on 24)

The method of claim 24 wherein the second PCR utilizes one universal primer when the universal tail of the forward and reverse primers of the first PCR is same, and wherein the second PCR utilizes two universal primers when the universal tail of the forward and reverse primers of the first PCR are different, wherein the one universal primer matches to the universal tail of the forward primers of the first PCR while the other universal primer matches to the universal tail of the reverse primers of the first PCR.

### Claim 26

A method for producing sufficiently pure methylated DNA fragments for determining the methylation status at a plurality of DNA CpG sites in a large background of unmethylated DNA, the method comprising: providing a DNA sample containing both methylated and unmethylated DNA; subjecting the DNA sample to bisulfite treatment; amplifying DNA sequences containing methylated CpG sites by multiplexed PCR to thereby produce amplicons; and enriching methylated DNA fragments containing the methylated CpG sites from the amplicons of the PCR.

### Claim 27 (depends on 26)

The method of claim 26 wherein the DNA sample is obtained from clinical biospecimens collected from patients, the biospecimens selected from the group consisting of human tumor tissues, peripheral blood, stool, urine, bodily fluids, washing fluids associated with medical procedures, and combinations thereof.

### Claim 28 (depends on 26)

The method of claim 26 wherein the molar ratio of the unmethylated DNA to the methylated DNA is about 2:1 to about 100,000:1 in the DNA sample.

### Claim 29 (depends on 26)

The method of claim 26 wherein the CpG sites are in one or more genes.

### Claim 30 (depends on 72)

The method of claim 72 wherein the bisulfite treatment converts unmethylated cytosine in the CpG sites to uracil whereas methylated cytosine in the CpG sites are unaltered.

### Claim 31 (depends on 30)

The method of claim 30 wherein the multiplexed PCR utilizes two or more pairs of PCR primers, wherein each pair of primers hybridize to a sequence containing one or more of the CpG sites for amplification of the sequence.

### Claim 32 (depends on 31)

The method of claim 31 wherein the multiplexed PCR converts uracil to thymine.

### Claim 33 (depends on 26)

The method of claim 26 wherein enrichment of the methylated DNA fragments containing the methylated CpG sites from the amplicons of the multiplexed PCR is performed by at least one of (i) methylation-specific hybridization and extraction and (ii) competing methylation-specific hybridization and extraction.

### Claim 34 (depends on 33)

The method of claim 33 wherein enriching is performed by methylation-specific hybridization and extraction, wherein a plurality of methylation-specific probes are contacted with the DNA fragments of the first PCR under hybridization conditions wherein each methylation-specific probe preferentially forms hybrids with a methylated sequence, wherein the methylation-specific probes are further attached to a first binding molecule that is capable of binding to a second binding molecule that is attached to a solid support, and wherein after hybridization, the hybrids are captured by the solid support containing the second binding molecule.

### Claim 35 (depends on 34)

The method of claim 34 wherein the number of competing methylation-specific hybridization and extraction cycles performed ranges from one cycle to five cycles.

### Claim 36 (depends on 35)

The method of claim 35 wherein the number of cycles is one.

### Claim 37 (depends on 35)

The method of claim 35 wherein the number of cycles is two or more.

### Claim 38 (depends on 37)

The method of claim 37 wherein the methylation-specific hybridization and extraction is repeated, wherein the DNA fragments captured by the solid support are released from the solid support and further subjected to additional cycles of the methylation-specific hybridization and extraction.

### Claim 39 (depends on 34)

The method of claim 34 wherein the methylation-specific probes are selected from the group consisting of oligonucleotides, peptide nucleic acids, locked nucleic acids, and combinations thereof.

### Claim 40 (depends on 34)

The method of claim 34 wherein the first binding molecule is selected from the group consisting of biotin, streptavidin, and combinations thereof and the second binding molecule is selected from the group consisting of streptavidin, biotin, and combinations thereof.

### Claim 41 (depends on 33)

The method of claim 33 wherein enriching of the methylated DNA fragments is performed by competing methylation-specific hybridization and extraction, wherein a plurality of methylation-specific probes and unmethylated competitor probes are contacted with the DNA fragments of the first PCR under hybridization conditions wherein the methylation-specific probes preferentially form hybrids with methylated DNA fragments, the corresponding unmethylated competitor probes preferentially form hybrids with the corresponding unmethylated DNA fragments, wherein the methylation-specific probes are further attached to a first binding molecule that is capable of binding to a second binding molecule that is attached to a solid support, and wherein after hybridization, the hybrids are captured by the solid support containing the second binding molecule.

### Claim 42 (depends on 41)

The method of claim 41 wherein the number of competing methylation-specific hybridization and extraction cycles performed ranges from one cycle to five cycles.

### Claim 43 (depends on 42)

The method of claim 42 wherein the number of cycles is one.

### Claim 44 (depends on 42)

The method of claim 42 wherein the number of cycles is two or more.

### Claim 45 (depends on 44)

The method of claim 44 wherein the competing methylation-specific hybridization and extraction is repeated, wherein the DNA fragments captured by the solid support are released from the solid support and further subjected to additional cycles of the competing methylation-specific hybridization and extraction.

### Claim 46 (depends on 41)

The method of claim 41 wherein the methylation-specific probes are selected from the group consisting of oligonucleotides, peptide nucleic acids, locked nucleic acids, and combinations thereof.

### Claim 47 (depends on 41)

The method of claim 41 wherein the first binding molecule is selected from the group consisting of biotin, streptavidin, and combinations thereof and the second binding molecule is selected from the group consisting of streptavidin, biotin, and combinations thereof.

### Claim 48 (depends on 41)

The method of claim 41 wherein the molar ratio of the methylation-specific hybridization probes to the corresponding unmethylated competitor probes is from about 0.02:1 to about 10:1.
